Quotes

Company Overview

Financial Analysis

Main Composition Key Indicators Financial Statement

Multi-dimentional Analyses

Company Valuation Capital Tracking Short Selling Data

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

CEO： Farid Ph.D., Ramy

Market： NASDAQ

Hot List

TradeSearchNews

SymbolLatest price%Chg

Moomoo > Quotes > SDGR Schrodinger > Detailed Quotes

SDGR Schrodinger

24.750+0.030+0.12%

Close 05/20 20:00 ET

24.700-0.05-0.20%

Post Mkt Price 05/20 18:05 ET

High

25.340

Open

25.070

Turnover

13.53M

Low

23.530

Pre Close

24.720

Volume

553.45K

Post-Market

Price Forecast

No Data

SDGR Schrodinger

News

Comment

News

Announcement

All

Earnings Report

Related Transactions

Changes In Ownership

Major Events

Other